Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer
Daniel J. Lee(University of Pennsylvania), Karen E. Hoffman(The University of Texas MD Anderson Cancer Center), Ralph Conwill(Vanderbilt-Ingram Cancer Center), David F. Penson(Geriatric Research Education and Clinical Center), Mia Hashibe(University of California, Los Angeles), Sherrie H. Kaplan(University of California, Irvine), Dan McCollum(Vanderbilt-Ingram Cancer Center), Daniel A. Barocas(Vanderbilt University Medical Center), Sheldon Greenfield(University of California, Irvine), Tatsuki Koyoma(Vanderbilt University Medical Center), Lisa E. Paddock(Rutgers, The State University of New Jersey), Li‐Ching Huang(Vanderbilt University), Matthew R. Cooperberg(University of California, San Francisco), Ann S. Hamilton(University of Southern California), Zhiguo Zhao(Vanderbilt University), Xiao‐Cheng Wu(Louisiana State University Health Sciences Center New Orleans), Antoinette M. Stroup(Rutgers, The State University of New Jersey), Matthew J. Resnick(Vanderbilt University Medical Center), Michael Goodman(Emory University)
Cited by 15
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
|Nature|2008|1.3k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688